Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ARHGAP27 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
TNFSF8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC389906 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
LOC100507073 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHL1-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLEKHA8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADAMTS17 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPAG16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP6AP1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM200B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRPM6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FOXN3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KCTD6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADAMTS9-AS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EGFR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STARD13-AS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDADC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on